EXDI - Exactus, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.1000
0.0000 (0.00%)
At close: 3:42PM EDT
Stock chart is not supported by your current browser
Previous Close0.1000
Open0.0901
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0900 - 0.1000
52 Week Range0.0610 - 1.5250
Volume33,369
Avg. Volume74,534
Market Cap4.956M
Beta (5Y Monthly)6.05
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
Press Releases
  • GlobeNewswire

    Exactus, Inc. Reports First Quarter 2020 Financial Results

    Exactus, Inc. (EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD/CBG) and feminized hemp genetics, today reported financial results for the first quarter 2020. During the first quarter of 2020, Exactus is pleased it has reported record revenue as its investment into sales and marketing has begun to generate revenue and scale. The Company has significantly cut its monthly cash burn and has shifted its focus to rapidly generate revenue through bulk specialty ingredient sales.

  • GlobeNewswire

    Exactus Appoints Leading Business Expert, Julian Pittam to Chairman of the Board of Directors

    Exactus, Inc. (EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD) and feminized hemp genetics, announced today the appointment of executive business leader, Julian Pittam to the Chairman of the Board. “Julian Pittam has been an investor and a friendly voice of wisdom since our inception, and we are honored to have him join as Chairman of the Board at this pivotal moment,” said Emiliano Aloi, Exactus Interim Chief Executive Officer. Julian started his career at Bankers Trust in sales and trading.

  • GlobeNewswire

    Exactus Announces its Hemp Seed Buyback Program to Assist Farmers Impacted by the COVID-19 Pandemic

    Exactus, Inc. (EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD) and feminized hemp genetics, announced today the institution of its Exactus Hemp Buyback Program in support of farmers who purchase seeds from the company. Exactus introduced its buyback program during this essential hemp planting season to aid farmers faced with hardships caused by the COVID-19 pandemic. With the launch of its buyback program, Exactus will buy back hemp biomass that meets their processing specifications at fair market value that meets the required specifications from farmers who purchase the company’s feminized CBD seeds.

  • GlobeNewswire

    Exactus, Inc. Reports 2019 Year End Results

    Exactus, Inc. (EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD/CBG) and feminized hemp genetics, today reported financial results for the year end 2019. During 2019, Exactus has built the foundation to become an industry leader. The Company completed its first harvest, entered into supply agreements with industry leaders, and has fully restructured the company and board of directors.

  • GlobeNewswire

    Exactus Appoints Technology Expert Mark Alouf to Its Advisory Board

    Exactus, Inc. (EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD/CBG) and feminized hemp genetics, announced today the appointment of Mark Alouf, Co-founder and COO of P1 Technologies to its Advisory Board. “We are happy to announce Mark Alouf’s involvement with our company and appointment to our Advisory Board,” said Andrew Johnson, Exactus Chief Strategy Officer.

  • GlobeNewswire

    Exactus Announces the Promotion of Derek Du Chesne as Company President and appointment to the Board of Directors

    Exactus, Inc. (EXDI) (the “Company”) a leading producer of hemp-derived ingredients (CBD/CBG) and feminized hemp genetics, announced today that the Company has promoted Derek Du Chesne to President. In less than 3 months with Exactus and various accolades, the Company has promoted Derek Du Chesne to President and appointed him to the Board of Directors. Derek was initially brought on as Chief Growth Officer, where he implemented internal infrastructure systems designed to scale while developing additional income streams for Exactus.

  • GlobeNewswire

    Exactus Appoints Co-Founder of Rokt Justin Viles to its Board of Directors

    Exactus, Inc. (EXDI) (the “Company”) a leading producer of hemp and hemp-derived specialty cannabinoid ingredients (CBD/CBG) and feminized hemp genetics, announced today the appointment of Justin Viles, Co-founder and Chief Innovation Officer of Rokt, a global leader in e-commerce technology to its Board of Directors. “We are very excited about the addition of Justin Viles to our Board of Directors,” said Derek Du Chesne, Exactus Chief Growth Officer.

  • GlobeNewswire

    Exactus Appoints Former Broadcast Media Executive Larry Wert to Its Board of Directors

    Exactus, Inc. (EXDI) (the “Company”) a leading producer of hemp-derived ingredients (CBD/CBG) and feminized hemp genetics, announced today the appointment of Larry Wert, former President of Tribune Broadcast Media to its Board of Directors. “It is truly a pleasure to have Larry on our Board of Directors,” said Andrew Johnson, Exactus Chief Strategy Officer.

  • GlobeNewswire

    Exactus, Inc. Launches a Genetics Division to Supply Farmers with FDA Compliant Feminized CBD and CBG Hemp Seeds

    Exactus, Inc. (EXDI) (the “Company”), a leading producer of hemp and hemp-derived specialty cannabinoid products, announced today that it has launched its genetics division to supply farmers with FDA compliant feminized CBD and CBG hemp seeds. Exactus is proud to expand its product portfolio to become a reliable source for farmers while continuing to provide the industry with the most in-demand hemp-derived specialty ingredients and consumer products, including CBD, CBG, CBN, CBC, and other specialty cannabinoids. The intention behind Exactus creating a genetics division is that with over 20 years of experience in agriculture the Company is equipped to advise farmers, helping them determine which genetics in the Exactus seed catalog will be superior for each region and farming methodology they are growing in.

  • GlobeNewswire

    Exactus, Inc. Launches CBG Initiative in Cooperation With Hemptown USA – Will Develop Supply Chain Initiatives With Kirkman Group cGMP Facilities

    Exactus Inc. will focus its efforts on farming, supply chain development, and international expansion with Hemptown USA (Hemptown Organics Corp) broadening supply arrangements with Exactus. This partnership is an important milestone positioning Exactus for rapid growth through this mutually beneficial CBD and CBG partner. The agreement includes aiding Hemptown’s management in the necessary compliance requirements for products, participating in discussions related to 2020 farming, harvesting and processing plans as well as joint supply scenarios.

  • GlobeNewswire

    2019 Annual Shareholder Letter

    Let us begin by expressing our gratitude to all of our shareholders for your commitment and trust as we move towards what is ramping up to be the most exciting year to come for Exactus Inc., which would not be possible without you. Following the 2018 Farm Bill, the company engaged in product development, supply, and management agreements with Ceed2Med, LLC to penetrate the emerging hemp industry. Through these agreements, Exactus secured an annual supply of industrial-scale hemp products (CBD) along with key industry experts and vast industry relationships.

  • GlobeNewswire

    Exactus Inc. appoints Derek Du Chesne as Chief Growth Officer and announces Company to present at NobleCon16

    Exactus, Inc. (EXDI) (the “Company”), a hemp farmer and manufacturer of hemp-derived phytocannabinoid products, today announced that it has appointed Derek Du Chesne as Chief Growth Officer and the company will be presenting at the NobleCon16 Investor Conference. Exactus welcomes Derek Du Chesne who joins the company as Chief Growth Officer.

  • GlobeNewswire

    Exactus, Inc. Enters into Supply & Distribution Agreement with Hemptown USA

    Exactus, Inc. (EXDI) (the “Company”), a hemp farmer and manufacturer of hemp-derived phytocannabinoid products, today announced that it has entered into a supply and distribution agreement with Hemptown USA. The supply and distribution agreement enables Exactus, Inc. the ability to purchase and sell Hemptown’s CBG and CBD raw materials, including top flower, biomass and extracts (crude, isolates, distillates, and water soluble).

  • GlobeNewswire

    Exactus, Inc. Appoints Daniel Alberttis to its Board of Directors

    Exactus, Inc. (EXDI) (the “Company”), a hemp farmer and manufacturer of hemp-derived phytocannabinoid products, today announced that it has appointed Daniel Alberttis to its Board of Directors. Daniel Alberttis is currently a Managing Director at The Kannico Agency, a global advisory firm focused on the nonprofit and philanthropic sectors based in Delray Beach, Fl.

  • GlobeNewswire

    Exactus, Inc. Jumpstarts Business With Addition of Senior Marketing, E-Commerce and Technology Executives

    Exactus, Inc. (EXDI) (the “Company”), a hemp farmer and manufacturer of hemp-derived phytocannabinoid products, today announced new initiatives to expand its sales, marketing and distribution by establishing new e-commerce platforms with the addition of experienced professionals responsible for building out its wholesale, retail and direct to consumer sales channels. Through these efforts and the addition of new personnel, the Company will be able to expand its sales of branded consumer products while focusing on developing its manufacturing and distribution of CBD products produced from its recently completed and highly successful 2019 harvest. Exactus has proven its farming proficiency as it turns to its planned entry into the highly lucrative direct to consumer, retail and wholesale markets for finished CBD consumer products.

  • GlobeNewswire

    Exactus, Inc. Issues Clarification Regarding Recent Note Issuance

    Exactus, Inc. (EXDI) (the “Company”), a hemp farmer and manufacturer of hemp-derived phytocannabinoid products, is issuing this statement to respond to certain inaccuracies reflected in public comments regarding its December 4, 2019 financing. On December 4, 2019 the Company entered into a financing arrangement with an institutional investor who agreed to purchase up to $2.0 million of the Company’s 8% senior secured convertible notes (the “8% Notes”) in three separate tranches. The Company is not obligated to sell the full $2.0 million of 8% Notes and on December 4, 2019 received the proceeds from the sale of $750,000 of 8% Notes (and issued a note in the amount of $833,333 reflecting original issue discount).

  • GlobeNewswire

    Exactus, Inc. to Present at the 12th Annual LD Micro Main Event Investor Conference on December 10, 2019

    Exactus, Inc. (EXDI) (the “Company”), a farmer and manufacturer of hemp-derived phytocannabinoid products, today announced that it will be presenting at the 12th Annual LD Micro Main Event on December 10th, 2019 at 10 am PT / 1 pm ET at the Luxe Sunset Boulevard Hotel in Los Angeles, California . Emiliano Aloi, President and CEO and Andrew Johnson, Chief Strategy Officer of Exactus, Inc. will be presenting and meeting with investors throughout the day. LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space.

  • GlobeNewswire

    Exactus, Inc. Announces Closing of $2 Million Convertible Note

    Exactus, Inc. (EXDI) (the “Company”), an industrial hemp farm operator and manufacturer of hemp-derived phytocannabinoid products, today announced the closing of the initial tranche of a $2 million senior secured convertible note financing from a single institutional investor.

  • GlobeNewswire

    Exactus, Inc. Signs Cool & Dre Endorsement and Co-Branding Deal

    Exactus, Inc. (EXDI) (the “Company”), an industrial hemp farm operator and manufacturer of hemp-derived phytocannabinoid products, today announced that it has signed an endorsement and co-branding deal with Grammy Nominated celebrity producer and songwriter duo Cool & Dre. Cool & Dre launched their record company Epidemic Music in 2004 and are known for working with the best of the best in the music industry including Beyonce, Jay-Z, Kendrick Lamar, Drake, French Montana, DJ Khaled, Big Sean, Tyga, 50 Cent, Lil Wayne, The Game, Nas, Rick Ross, Fabolous, Queen Latifa, Ja Rule, Fat Joe, Busta Rhymes, Young Jeezy, just to name a few.

  • GlobeNewswire

    Exactus, Inc. Enters into Supply & Distribution Agreement with Canntab Therapeutics to Produce Immediate and Extended Release Tablets

    Exactus, Inc. (EXDI) (the “Company”), an industrial hemp farm operator and manufacturer of hemp-derived phytocannabinoid products, today announced that it has entered into a supply and distribution agreement with Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQX:CTABF) (FRA:TBF1.F) to produce immediate and extended release tablets. Exactus will provide Canntab a subleased space in their facility in Florida to equip for the purpose of manufacturing advanced hemp derived cannabinoid tablets.

  • GlobeNewswire

    Exactus, Inc. Enters into Supply and Distribution Agreement with Ceed2Med

    Exactus, Inc. (EXDI) (the “Company”), an industrial hemp farm operator and manufacturer of hemp-derived phytocannabinoid products, today announced that it has entered into a supply agreement to provide Ceed2Med a minimum of 10,000 lbs of 2019 harvested flower from the Company’s 200 acre farms in Southwest Oregon.

  • GlobeNewswire

    Exactus, Inc. Reports Third Quarter 2019 Results

    Second Half 2019 Highlights Acquired Green Goddess Extracts and launched CBD brandsIncreased expected harvest of top flower to 30,000 poundsLaunched e-Commerce marketplace.

  • GlobeNewswire

    Exactus Inc. to Hold Third Quarter 2019 Financial Results Conference Call on Thursday, November 14, 2019

    Exactus Inc. (EXDI) – (the “Company”), a grower of hemp and producer of hemp-derived phytocannabinoid products, today announced that it plans to report its third quarter 2019 financial results after the U.S. markets close on Thursday, November 14, 2019 and will hold an investor conference call to discuss its financial results. Exactus, Inc. will hold a conference call on Thursday, November 14, 2019 at 4:30 p.m. Eastern time to discuss its financial results for the third quarter ended September 30, 2019. Exactus management will host an investor conference call to discuss its third quarter financial results and provide a general business update on Thursday, November 14, at 4:30 p.m. ET.

  • GlobeNewswire

    Exactus, Inc. Announces Initial Orders Exceed $750,000

    Exactus, Inc. (EXDI) (the “Company”), a grower of hemp and producer of hemp-derived phytocannabinoid products, is pleased to announce that it has obtained several significant orders and has commenced delivery of product from its current 2019 harvest. Additional biomass is being prepared for sale and production into ingredients and finished products for our own Green Goddess and other brands, as well as for sale to others. Emiliano Aloi, President & CEO of Exactus, said, “These orders show that we have been able to successfully navigate our evolution to growing and producing products derived from lawful hemp following adoption of the Agricultural Improvement Act of 2018 enacted in January 2019.

  • GlobeNewswire

    Exactus, Inc. Research Report Published by Proactive Investors

    Proactive Investors enables companies and investors to connect intelligently. To learn more about Exactus, Inc., visit the corporate website at www.exactusinc.com and the e-commerce website at www.exactushemp.com. Exactus Inc. is dedicated to introducing hemp-derived phytocannabinoid products into mainstream consumer markets.